Duncan Blaikie

Joined firm 2007. Partner since 2017.

Duncan is a partner in our Technology, Digital, Data and IP group. He advises clients on a full range of technology, data, intellectual property and commercial contract matters across all sectors, including in relation to M&A transactions, complex business carve outs, emerging technology and digital strategy.

Duncan was a medical doctor prior to becoming a lawyer and also advises across a range of transactions in the pharmaceutical, biotechnology and healthcare fields.

He is named in Legal 500 UK, 2024 as a Leading Individual for IT & Telecoms and Commercial Contracts.

His experience includes advising:

  • Reckitt Benckiser on the brand and services aspects of: (i) the sale of its Infant Formula and Child Nutrition business in China to Primavera Capital Group; and (ii) the sale of Scholl to Yellow Wood Partners
  • Zurich Insurance plc on the business migration and outsourcing arrangements relating to the transfer of its pre-2007 UK legacy employers’ liability portfolio to Catalina
  • Vodafone on its strategic service procurement arrangements relating to: (i) its joint venture with Liberty Global in the Netherlands; (ii) the merger of Vodafone India with Idea Cellular; and (iii) its purchase of Liberty Global’s operations in Germany and CEE
  • GSK on the divestment of its core consumer healthcare nutrition brands to Unilever
  • Burberry on its strategic partnership with Coty Inc. in relation to Burberry's beauty business
  • Ericsson in connection with its IT transformation and build program for Veon across Europe and Asia
  • Whitbread on the business critical services arrangements relating to its sale of Costa to The Coca-Cola Company